3-D study delivers first pre-clinical results on the toxicological impact of novel e-cigarette

Singapore - Philip Morris International (PMI), has conducted an in vitro study using epithelial cells taken from the mou...

November 12, 2018 | Monday | News
Adagene announces acceptance of IND in China for ADG-106

Adagene, an innovative antibody engineering and discovery company based in Suzhou, China as well as San Francisco, Calif...

November 1, 2018 | Thursday | News
Daiichi enters clinical collaboration with Merck, Pfizer

Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement with Merck K...

October 27, 2018 | Saturday | News
Eisai announces Data from the Phase II Clinical Trial of BAN2401

Eisai Co., Ltd. and Biogen Inc. announced that Eisai presented the latest data from the Phase II clinical study (Study 2...

October 26, 2018 | Friday | News
Reistone Biopharma to intiate Ph 2 clinical trial of Ulcerative Colitis globally

Reistone Biopharma Company Limited, a clinical stage biopharmaceutical company headquartered in Shanghai has announced&...

October 23, 2018 | Tuesday | News
ASLAN reveals promising data for advanced solid tumour drug

Singapore – ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both...

October 22, 2018 | Monday | News
apceth Biopharma announces positive results for apceth-201 in mouse models

apceth Biopharma GmbH, a company with the mission of improving patients’ lives with next generation cell therapies...

October 19, 2018 | Friday | News
Medivir lowers research costs to focus on clinical development

Singapore - Medivir AB announced plans to reduce activities not critical to its development pipeline of drug candidates ...

October 17, 2018 | Wednesday | News
Alphamab starts phase I clinical trial in Australia

Alphamab Oncology has announced that its proprietary humanized PD-L1 - CTLA-4 bispecific antibody program, the first of ...

October 11, 2018 | Thursday | News
Yisheng receives approval for rabies vaccine clinical study

Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and mar...

October 10, 2018 | Wednesday | News
Eisai receives FDA approval for antiepileptic drug

Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administ...

October 1, 2018 | Monday | News
Atox Bio announces completion of pre-planned safety review

Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients has announced th...

September 25, 2018 | Tuesday | News
Immutep collaborates with Merck, Pfizer for Efti

Immutep Limited has announced that it has entered into a clinical trial collaboration and supply agreement with Merck KG...

September 25, 2018 | Tuesday | News
Proxima Clinical Research appoints David Novotny as CSO

David T. Novotny was recently named Chief Strategy Officer (CSO) of Proxima Clinical Research, Inc., a leader in clinica...

September 24, 2018 | Monday | News
“The role of laboratories will be central to the delivery of high quality healthcare”: Jozika Habijanic

Excerpts from the interview In the context of emerging markets in APAC, what are some of the opportunities and challeng...

September 20, 2018 | Thursday | Opinion
Innovent presents clinical data of Sintilimab

Innovent Biologics, a world-class China-based biopharmaceutical company that develops and commercializes high quality dr...

September 20, 2018 | Thursday | News
CISCRP releases a video to improve diversity in clinical research

The Center for Information and Study on Clinical Research Participation (CISCRP), a Boston-based nonprofit organization,...

September 19, 2018 | Wednesday | News
Daily intake of Aspirin has little effect on cardiovascular disease, says a study

Three groundbreaking papers published in New England Journal of Medicine, led by a team of Monash University researchers...

September 17, 2018 | Monday | News